# A Study to Learn About Recifercept in Patients With Achondroplasia

> **NCT05659719** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 248 (actual)

## Conditions studied

- Achondroplasia

## Interventions

- **OTHER:** Recifercept

## Key facts

- **NCT ID:** NCT05659719
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-19
- **Primary completion:** 2023-05-16
- **Final completion:** 2023-05-16
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05659719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05659719, "A Study to Learn About Recifercept in Patients With Achondroplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05659719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*